NVE Corporation targets medical device miniaturization with new wafer-level chip scale sensor as distributor sales rebound

Earnings Call Insights: NVE Corporation (NVEC) Q3 2026

MANAGEMENT VIEW

* Daniel Baker, CEO, announced "a 23% increase in revenue and an 11% increase in earnings for the third quarter of fiscal 2026 compared to the prior year quarter, driven by broad-based growth across our revenue lines, including defense and nondefense sales as well as distributor and direct channels."
* Daniel Nelson, Accounting Manager & Principal Financial Officer, stated: "Revenue for the third quarter of fiscal 2026 increased 23% year-over-year. The increase was due to a 16% increase in product sales and a 335% increase in contract R&D revenue."
* Nelson further shared, "Gross margin for the third quarter of fiscal 2026 was 79% of revenue compared with 84% in the prior year quarter. The decrease in gross margin percentage was due to a less profitable product mix and increased distributor sales for the quarter."
* Nelson noted, "Total operating expenses decreased 12% for the third quarter of fiscal 2026 compared to the third quarter of fiscal 2025 due to a 9% decrease in R&D expense and a 19% decrease in SG&A."
* Peter Eames, Vice President of Advanced Technology, explained, "New equipment in the past year has increased our capacity, increased our capabilities and allowed us to do smaller and more precise wafer-level chip scale package parts in-house... We completed installation and calibration of a new equipment cluster in the past quarter in an expanded production area."
* Eames also announced, "Just yesterday, we announced a new wafer-level chip scale sensor a part that's just 0.65 millimeter square... This tiny size allows for unmatched miniaturization and special sensitivity."
* Baker highlighted a key customer development: "In the past quarter, we executed an extension to our supplier partnering agreement with Abbott... this extension is for 2 years through December 31, 2027. It provides for price increases for 2026 and 2027."

OUTLOOK

* Nelson stated, "We currently expect a full year tax rate of 16% to 17% in fiscal 2026 because we expect advanced manufacturing investment tax credits of between $700,000 and $1 million to offset the impact of other tax law changes."
* Nelson added, "We expect accelerated deductions of previously unamortized research and development expenses to reduce our cash taxes for the full fiscal year ending March 31, 2026 by approximately $1.1 million."
* Eames shared, "We expect to place new equipment into service by March 31."

FINANCIAL RESULTS

* Nelson reported, "Net income increased 11% to $3.38 million or $0.70 per diluted share from $3.05 million or $0.63 per share."
* "Operating margin was 60%. Pretax margin was 68% and net margin was 54%."
* For the first 9 months of fiscal 2026, "total revenue increased 0.4% to $18.7 million from $18.6 million for the 9 months of the prior year as growth in the most recent quarter more than offset year-over-year decreases in the first 2 quarters of the fiscal year."
* "Net income for the 9 months decreased 8% to $10.3 million or $2.12 per diluted share."
* Cash flow from operations was $12.2 million in the first 9 months of the fiscal year. Accounts receivable decreased $1.1 million during the first 9 months primarily due to the timing of customer payments. Inventories decreased by $177,000 due to increased product sales.
* Fixed asset purchases were $2.18 million for the first 9 months of the fiscal year, including $1.05 million in the December quarter. "We substantially completed spending on our 2-year multimillion dollar expansion."

Q&A

* Jeffrey Bernstein, Cowen Inc.: "So we talked during the quarter about this idea of magnetic navigation in GPS compromised areas and whether your magnetometer sensors were appropriate for that kind of application. Can you just talk a little bit about that and if you made any contact with anybody in the BOW about this?" Eames replied, "We have looked at MagNav... it's one of the things that we keep an eye on in the defense community to see how it evolves."
* Bernstein: "Do you have a part that you would deem appropriate for that application today or now?" Eames: "Not exactly. MagNav is pretty new... it's not a mature enough technology that we would chase it for example."
* Unknown Analyst: "Your new equipment up and running in March... Is that pretty much on the expected schedule that you thought?" Baker: "It is... So things are going well, and we were -- it's a complicated piece of -- set of equipment and a complicated process, but our guys have done a great job of getting it done on schedule."
* Unknown Analyst: "Is there an expectation that, that new equipment will help with new product sales like adding to new revenue and/or... better profitability because it's packaging, right?" Eames: "I think there is a lot of optimism surrounding the technology that we're developing with the new equipment."
* Unknown Analyst: "Do you guys see the distributors building up inventory?" Baker: "Yes, it is. It's very positive... our distributor sales are picking up and have been through the fiscal year."
* Bernstein: "Application for rare earth magnets for position sensing? And what kind of traction you've gotten there?..." Baker: "Our sensors are uniquely positioned to use rare earth free ferrite magnets... we have gotten some sales, and we've gotten some interest in both the magnets and in the sensors that go with them."
* Unknown Shareholder: "Comments you can make on the current quarter, especially... your defense business, which happens to be a little bit more volatile?" Eames: "I think we're optimistic going forward. I think it's safe to say that we'll be returning to somewhat of a more normal flow there if that's of any help."

SENTIMENT ANALYSIS

* Analysts expressed optimism about distributor sales recovery and new equipment deployment, but pressed for details on defense business volatility and MRAM opportunities, reflecting a neutral to slightly positive tone.
* Management maintained a confident and constructive tone throughout, emphasizing on-schedule equipment rollout and robust customer relationships, supported by phrases like "we're pleased with how it's going" and "I think there is a lot of optimism."
* Compared to the previous quarter, both analysts and management appeared more upbeat, with greater focus on growth catalysts and less on margin pressures or segment volatility.

QUARTER-OVER-QUARTER COMPARISON

* The current quarter featured a more pronounced increase in both revenue and earnings, contrasted with the prior quarter's modest sequential revenue growth and year-over-year declines.
* Management's tone has shifted from cautious optimism to a more upbeat and confident outlook, highlighting execution of strategic customer agreements and successful equipment expansion.
* Analysts' questions this quarter centered more on new products and capacity utilization, while last quarter included more supply chain and margin-focused concerns.
* The strategic focus has evolved from discussion of capability and product development to practical deployment and sales momentum, underpinned by the new wafer-level sensor launch and the Abbott agreement extension.

RISKS AND CONCERNS

* Nelson highlighted that gross margin decreased due to "a less profitable product mix and increased distributor sales for the quarter."
* The increase in effective tax rate was attributed to "the noncash impact of tax law changes on certain tax deductions this fiscal year."
* Supply chain improvements and distributor inventory normalization were noted, but no new macroeconomic or operational risks were introduced in this call.

FINAL TAKEAWAY

NVE Corporation reported strong revenue and earnings growth for the quarter, supported by improved distributor sales, a new 2-year extension with Abbott, and the rollout of advanced wafer-level chip scale sensors. The leadership team highlighted optimism around the impact of newly installed equipment on production capacity and future product launches, signaling confidence in both operational execution and expanded opportunities in medical and industrial markets.

Read the full Earnings Call Transcript [https://seekingalpha.com/symbol/nvec/earnings/transcripts]

MORE ON NVE

* NVE Corporation (NVEC) Q3 2026 Earnings Call Transcript [https://seekingalpha.com/article/4861700-nve-corporation-nvec-q3-2026-earnings-call-transcript]
* Seeking Alpha’s Quant Rating on NVE [https://seekingalpha.com/symbol/NVEC/ratings/quant-ratings]
* Dividend scorecard for NVE [https://seekingalpha.com/symbol/NVEC/dividends/scorecard]
* Financial information for NVE [https://seekingalpha.com/symbol/NVEC/income-statement]